Frontera Health and Motivity say their AI assessment integration is available now to ABA providers, but neither has disclosed terms or the technical scope.
Key Takeaways
- The announcement: Motivity said in an August 12 post on its company blog that the integration is available now to all its customers, and Frontera Chief Executive Amol Deshpande followed on LinkedIn a day later with a broader framing. Neither company has disclosed terms or how the two systems technically connect.
- Who Motivity is: Motivity is a Honolulu-based ABA clinical data collection and practice management platform founded in 2012, built on more than $11 million in NIH Small Business Innovation Research grants and recapitalized with a $27 million investment from Five Elms Capital in March 2025. In May it acquired Calmanac, consolidating clinical and administrative workflows into a single stack.
- The friction: Deshpande told Acuity in June that incumbent vendors function as data monopolies that lock in clinics and build moats around their data. His post carves Motivity out as an exception rather than retreating from the critique.
- What operators should watch: The question that matters for buyers is whether the integration runs on sanctioned APIs or bolts onto the user interface, a distinction that determined which automations survived the Thoughtful AI wind-down. Both companies describe the workflow in outcome terms and neither documents the connection itself, which is the detail that decides what survives if the arrangement ends.
Motivity, the applied behavior analysis software vendor, said on August 12 that it has partnered with Frontera Health to cut the hours behavior analysts spend writing assessment reports. The announcement came in a post on the company’s blog by Cara Lechleiter, its Head of Partnerships and Strategic Accounts, and it describes the integration as available now to all Motivity customers.
A day later, Amol Deshpande, the Chief Executive and co-founder of Frontera, posted his own version on LinkedIn, framed considerably wider. The two companies would bring what he called “next-generation AI” to electronic health records, practice management, and clinical practice generally. He named three Motivity leaders by way of endorsement, credited the company with “investing in the future” rather than protecting the past, and wrote that Frontera’s role is to build tools that can operate inside the Motivity system. A graphic beneath the post paired the two logos under the label “New Partnership.”
Between the two accounts sits a gap. Motivity describes a specific sequence: a behavior analyst uploads assessment results, parent interviews, and observations, Frontera drafts a report and a recommended treatment plan, an automated check flags gaps before submission, and the analyst reviews and finalizes. Deshpande describes a technology partnership in the abstract.
Neither describes how the software actually connects, and neither has disclosed terms. The companies have scheduled a joint webinar for August 25 to walk customers through it.
What Frontera and Motivity Each Bring to the Partnership
Frontera Health is a Denver-based company founded in 2023 that launched in February 2025, backed by $32 million in seed funding co-led by Lux Capital and Lightspeed Venture Partners, with Bison Ventures, Menlo Ventures, and Inspired Capital participating. It sells AI assessment and diagnostic report builders to ABA clinics and runs its own clinics in rural New Mexico and Colorado. It has been assembling partnerships at pace, including one with the nonprofit Catalight in January and a forthcoming earliest-detection program with the biomarker company LinusBio.
Motivity is the older company and the larger installed base. Founded in 2012 and based in Honolulu, it built its clinical data collection platform on more than $11 million in Small Business Innovation Research grants from the National Institute of Mental Health, then took a $27 million growth investment from Five Elms Capital in March 2025. Smith Anderson, previously an operator at Five Elms, became Chief Executive at that point, founder Rex Jakobovits moved to Chief of Strategy and Innovation, and Emaley McCulloch, a Board Certified Behavior Analyst, serves as Chief Clinical Officer. Those three are the leaders Deshpande named in his post.
In May, Motivity acquired Calmanac, the practice management platform built by hBITS and hardened inside the operational demands of the Center for Autism and Related Disorders. Terms were not disclosed. The deal folded clinical and administrative workflows into one stack and brought Calmanac’s two co-founders onto Motivity’s executive team.
Why an ABA Software Consolidator Wants an Outside AI Partner
That acquisition is the context that makes this announcement worth reading closely. Motivity has spent the past year becoming an all-in-one platform, broadly the category Deshpande criticized in an interview with Acuity in June, when he described incumbent vendors as data monopolies that prevent innovation and build moats around clinics’ data. Frontera’s commercial argument, selling tokens consumed per assessment rather than annual seat licenses, was built as the alternative to that model. His post handles the friction by carving out an exception rather than retreating from the critique. “Some companies live in the past and some go to the future,” he wrote, placing Motivity in the second category.
It is also less of a departure than the announcement’s framing suggests. Frontera has not anchored itself to a single practice management spine, and its own marketing says its builders can be integrated into several popular practice management systems. Sitting inside someone else’s platform is the company’s distribution model, not an exception to it.
Motivity, for its part, has said the arrangement is consistent with how it intends to operate. Anderson told Acuity in May that the company’s posture toward interoperability would not change even as practice management shifted from a partnership to a core competency. “No platform should assume it can or should do everything,” he said.
The Integration Question ABA Operators Should Ask
For clinics, the practical question is how the software actually connects. Acuity reported in May, during the Thoughtful AI wind-down, that the distinction between sanctioned API access and user-interface automation determined which ABA workflows survived a vendor transition and which broke. Automations built against a platform’s documented endpoints held. Those that navigated the interface proved brittle, resource-heavy, and in some cases were shut off by the platform vendor outright.
Motivity’s description gestures at an answer without giving one. The company frames part of the problem as the manual work of translating a finalized treatment plan into the system where programs and targets get built, which implies Frontera’s output lands somewhere in the Motivity record. Whether it arrives through documented endpoints or through the interface is not stated.
The related question is durability. Operators who lived through Thoughtful AI’s exit learned to treat vendor structure and roadmap commitments as diligence criteria rather than footnotes, and an integration announced without terms or a support commitment still does not give them much to evaluate.
None of which makes the partnership unserious. Frontera’s report builders address the documentation burden that behavior analysts consistently name as a driver of burnout, and access to Motivity’s installed base is a meaningful commercial channel. Deshpande’s argument that AI should leverage scarce clinical time rather than replace it tracks with where the field’s ethics conversation has landed.
But what exists today is a marketing description on two company channels. The version worth writing about at length is the one with a documented integration and a support commitment standing behind it.
